FDA Alert: Hintermann Series H3 Total Ankle Replacement — What to Do Now
On June 3, 2026, the FDA updated its safety communication for the Hintermann Series H3 total ankle replacement. If your ankle is working well, FDA does not recommend surgery to remove the implant—but you should keep follow-up appointments and contact your clinician promptly if you notice new or worsening symptoms such as pain, swelling, inability to bear weight, instability, unusual noises, or weakness around the device.
